JP Patent

JP2021512117A — 嚢胞性線維症を処置するための医薬組成物

Assigned to Vertex Pharmaceuticals Inc · Expires 2021-05-13 · 5y expired

What this patent protects

化合物Ｉ：を含む医薬組成物。かかる医薬組成物のうちの１つ以上を患者に投与することを含む嚢胞性線維症を処置する方法。

USPTO Abstract

化合物Ｉ：を含む医薬組成物。かかる医薬組成物のうちの１つ以上を患者に投与することを含む嚢胞性線維症を処置する方法。

Drugs covered by this patent

Patent Metadata

Patent number: JP2021512117A
Jurisdiction: JP
Classification: —
Expires: 2021-05-13
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.